|
⚲
|
| Keyboard |
| White Marvin L
✚
|
|
|---|---|
| CIK # | 0001493324 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001493324] | |
| 4 | [0001493324] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| White Marvin L | |
| Emergent BioSolutions Inc | |
| Aptevo Therapeutics Inc | |
| CoLucid Pharmaceuticals Inc | |
| Washington Prime Group Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Aptevo Therapeutics Inc APVO
Restricted Stock Unit · derivative
|
2025-08-06 | Grant | 30,000 | $0.00 | |
|
Aptevo Therapeutics Inc APVO
Common Stock
|
2025-07-17 | Option exercise | 10 | ||
|
Aptevo Therapeutics Inc APVO
Restricted Stock Unit · derivative
|
2025-07-17 | Option exercise | 10 | $0.00 | |
|
Emergent BioSolutions Inc EBS
Common Stock
|
2025-04-30 | Grant | 34,403 | $0.00 | |
|
Emergent BioSolutions Inc EBS
Stock Option (Right to Buy) · derivative
|
2025-04-30 | Grant | 15,824 | $0.00 | |
|
Aptevo Therapeutics Inc APVO
Restricted Stock Unit · derivative
|
2025-03-03 | Option exercise | 6 | $0.00 | |
|
Aptevo Therapeutics Inc APVO
Common Stock
|
2025-03-03 | Option exercise | 6 | ||
|
Aptevo Therapeutics Inc APVO
Common Stock
|
2025-03-02 | Option exercise | 8 | ||
|
Aptevo Therapeutics Inc APVO
Restricted Stock Unit · derivative
|
2025-03-02 | Option exercise | 8 | $0.00 | |
|
Emergent BioSolutions Inc EBS
Common Stock
|
2024-11-11 | Sell | 14,287 | $11.97 | 171,015 |
|
Aptevo Therapeutics Inc APVO
Restricted Stock Unit · derivative
|
2024-07-17 | Grant | 22,325 | $0.00 | |
|
Emergent BioSolutions Inc EBS
Stock Option (Right to Buy) · derivative
|
2024-05-23 | Grant | 25,748 | $0.00 | |
|
Emergent BioSolutions Inc EBS
Common Stock
|
2024-05-23 | Grant | 17,430 | $0.00 | |
|
Aptevo Therapeutics Inc APVO
Common Stock
|
2024-03-03 | Option exercise | 9,584 | ||
|
Aptevo Therapeutics Inc APVO
Restricted Stock Unit · derivative
|
2024-03-03 | Option exercise | 9,584 | $0.00 | |
|
Aptevo Therapeutics Inc APVO
Restricted Stock Unit · derivative
|
2024-03-02 | Option exercise | 12,917 | $0.00 | |
|
Aptevo Therapeutics Inc APVO
Common Stock
|
2024-03-02 | Option exercise | 12,917 | ||
|
Aptevo Therapeutics Inc APVO
Common Stock
|
2024-01-28 | Option exercise | 4,792 | ||
|
Aptevo Therapeutics Inc APVO
Restricted Stock Unit · derivative
|
2024-01-28 | Option exercise | 4,792 | $0.00 | |
|
Emergent BioSolutions Inc EBS
Common Stock
|
2023-05-25 | Grant | 33,847 | $0.00 | |
| showing 20 of 100 most recent transactions | |||||